1,060 top medical experts on Status Epilepticus across 60 countries and 41 U.S. states, including 978 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.
- Status Epilepticus: A prolonged seizure or seizures repeated frequently enough to prevent recovery between episodes occurring over a period of 20-30 minutes. The most common subtype is generalized tonic-clonic status epilepticus, a potentially fatal condition associated with neuronal injury and respiratory and metabolic dysfunction. Nonconvulsive forms include petit mal status and complex partial status, which may manifest as behavioral disturbances. Simple partial status epilepticus consists of persistent motor, sensory, or autonomic seizures that do not impair cognition (see also epilepsia partialis continua). Subclinical status epilepticus generally refers to seizures occurring in an unresponsive or comatose individual in the absence of overt signs of seizure activity. (From N Engl J Med 1998 Apr 2;338(14):970-6; Neurologia 1997 Dec;12 Suppl 6:25-30)
- Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
- Broader Categories (#Experts): Seizures (4,922) and Narrower Categories: Epilepsia Partialis Continua (424).
- Clinical Trials
: at least 81 including 37 Completed, 17 Recruiting
- Synonyms: Absence Status, Complex Partial Status Epilepticus, Generalized Convulsive Status Epilepticus, Non-Convulsive Status Epilepticus, Petit Mal Status, Simple Partial Status Epilepticus
- Lowenstein, Daniel H NeurologyDepartment of Neurology, University of California, San Francisco, California, USA. Top HospitalSubjects: Anticonvulsants; Benzodiazepines; Midazolam; Levetiracetam; LorazepamCategories: Administration & Dosage; Drug Therapy; Therapeutic Use; Therapy; Diagnosis; Methods
- Loddenkemper, Tobias PediatricsDivision of Epilepsy and Clinical Neurophysiology, Department of Neurology, Boston Childrens Hospital, Harvard Medical School, Boston, MA, USA. Top HospitalSubjects: Anticonvulsants; Drug Resistant Epilepsy; Benzodiazepines; Seizures; SleepCategories: Drug Therapy; Therapeutic Use; Physiopathology; Diagnosis; Methods; Therapy
- Silbergleit, Robert Emergency MedicineDepartment of Emergency Medicine, University of Michigan, Ann Arbor, Michigan, USA.Relevant US NIH Grant Funding: $5,975,259 over the last 5 yearsDisclosed payments in 2021 from 3 biomedical companies, totalling $1,275, including $1,270 from PFIZER INC.Subjects: Anticonvulsants; Midazolam; Lorazepam; Levetiracetam; PhenytoinCategories: Drug Therapy; Administration & Dosage; Therapeutic Use; Methods; Therapy; Analogs & Derivatives
- Claassen, Jan Neurocritical CareDepartment of Neurology, Columbia University Irving Medical Center, New York, NY.Subjects: Anticonvulsants; Critical Care; Emergency Medical Services; Drug Resistant Epilepsy; KetamineCategories: Drug Therapy; Therapeutic Use; Methods; Administration & Dosage; Etiology; Diagnosis
- Bleck, Thomas P Critical Care MedicineFeinberg School of Medicine, Northwestern University, Chicago, Illinois. Top HospitalMedical school: Rush Medical College of Rush University (MD, 1977)Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 86.9/100Disclosed payments in 2021 from 6 biomedical companies, totalling $7,965.77, including $7,875 from Sage Therapeutics, Inc.Subjects: Anticonvulsants; Benzodiazepines; Clinical Trials as Topic; Critical Care; LevetiracetamCategories: Administration & Dosage; Drug Therapy; Therapeutic Use; Standards; Therapy; Diagnosis
- Kapur, Jaideep Neurological SurgeryDepartment of Neurology and Department of Neuroscience, Brain Institute, University of Virginia, Charlottesville, Virginia, USA. Top HospitalRelevant US NIH Grant Funding: $8,065,924 over the last 5 yearsMedical school: Other (MD, 1985)Medicare AcceptedSubjects: Anticonvulsants; Receptors, AMPA; Levetiracetam; Phenytoin; SeizuresCategories: Metabolism; Physiology; Drug Therapy; Physiopathology; Administration & Dosage; Therapeutic Use
- Chamberlain, James M Pediatric Emergency MedicineDivision of Emergency Medicine, Childrens National Hospital and the Department of Pediatrics and Emergency Medicine, School of Medicine and Health Sciences, George Washington University, Washington, District of Columbia, USA.Relevant US NIH Grant Funding: $5,975,259 over the last 5 yearsDisclosed payments in 2021 from 6 biomedical companies, totalling $80.77, including $44.45 from Lundbeck LLCSubjects: Anticonvulsants; Diazepam; Lorazepam; Levetiracetam; PhenytoinCategories: Therapeutic Use; Drug Therapy; Administration & Dosage; Pharmacokinetics; Analogs & Derivatives; Diagnosis
- Topjian, Alexis A Pediatric Critical Care MedicineDivision of Critical Care Medicine, The Childrens Hospital of Philadelphia, The Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. Top HospitalSubjects: Anticonvulsants; Drug Resistant Epilepsy; Benzodiazepines; Time-to-Treatment; Critical IllnessCategories: Drug Therapy; Physiopathology; Therapeutic Use; Diagnosis; Therapy; Administration & Dosage
- Mikati, Mohamad A PediatricsDivision of Pediatric Neurology, Duke University Medical Center, Duke University, Durham, NC, USA. Top HospitalSubjects: Drug Resistant Epilepsy; Anticonvulsants; Benzodiazepines; Time-to-Treatment; Diet, KetogenicCategories: Drug Therapy; Physiopathology; Therapeutic Use; Administration & Dosage; Diagnosis; Statistics & Numerical Data
- Dlugos, Dennis J PediatricsDivision of Neurology, The Childrens Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, 34th Street and Civic Center Boulevard, Colket Translational Research Building, 10th floor, Philadelphia, PA 19104, USA. Electronic address: . Top HospitalDisclosed payments in 2021 from 14 biomedical companies, totalling $18,595.99, including $4,250 from GW Research LimitedSubjects: Seizures; Critical Illness; Electroencephalography; Anticonvulsants; Brain DiseasesCategories: Diagnosis; Drug Therapy; Epidemiology; Etiology; Complications; Physiopathology
- Tasker, Robert C Pediatric Critical Care MedicineDepartment of Neurology, Department of Anesthesiology, Critical Care and Pain Medicine, Boston Childrens Hospital, Harvard Medical School, Boston, MA, USA. Top HospitalSubjects: Anticonvulsants; Drug Resistant Epilepsy; Benzodiazepines; Time-to-Treatment; Critical CareCategories: Drug Therapy; Therapeutic Use; Administration & Dosage; Diagnosis; Methods; Physiopathology
- Hirsch, Lawrence J NeurologyComprehensive Epilepsy Center, Department of Neurology, Yale University School of Medicine, New Haven, Connecticut, U.S.A.; and. Top HospitalDisclosed payments in 2021 from 24 biomedical companies, totalling $15,426.81, including $8,950.5 from Eisai Inc.Subjects: Drug Resistant Epilepsy; Seizures; Anticonvulsants; Consensus; EncephalitisCategories: Diagnosis; Therapy; Classification; Therapeutic Use; Administration & Dosage; Complications
- Foreman, Brandon P NeurologyDivision of Neurocritical Care, Department of Neurology, University of Cincinnati Academic Health Center, Cincinnati, Ohio.Physician Highly CitedDisclosed payments in 2021 from 52 biomedical companies, totalling $37,297.98, including $37,252.92 from UCB, Inc.Subjects: Pentobarbital; Seizures; Analgesics; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; AnticonvulsantsCategories: Administration & Dosage; Complications; Diagnosis; Therapy; Drug Therapy; Therapeutic Use
- Wasterlain, Claude Guy NeurologyDepartment of Neurology, David Geffen School of Medicine at UCLA, and VA Greater Los Angeles Health Care System, VA Medical Center 127, West Los Angeles, California, U.S.A.Subjects: Anticonvulsants; Brain; Hippocampus; Benzodiazepines; Drug Resistant EpilepsyCategories: Drug Therapy; Therapeutic Use; Pathology; Metabolism; Pharmacology; Physiology
- Rosenthal, Eric S NeurologyDepartment of Neurology, Divisions of Clinical Neurophysiology and Neurocritical Care Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. Top HospitalDisclosed payments in 2021 from 6 biomedical companies, totalling $11,303.27, including $11,212.5 from UCB, Inc.Subjects: Drug Resistant Epilepsy; Anesthetics; Anticonvulsants; Disease Management; ElectroencephalographyCategories: Drug Therapy; Methods; Therapeutic Use; Therapy; Surgery; Administration & Dosage
- Conwit, Robin A NeurologyNational Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.Subjects: Anticonvulsants; Benzodiazepines; Levetiracetam; Lorazepam; MidazolamCategories: Administration & Dosage; Drug Therapy; Therapeutic Use; Analogs & Derivatives; Standards; Drug Effects
- Kossoff, Eric Heath NeurologyJohns Hopkins Hospital, 200 North Wolfe Street, Baltimore, MD 21287, United States. Electronic address: .Medical school: State University of New York at Buffalo School of Medicine (MD, 1995)Medicare AcceptedDisclosed payments in 2021 from 2 biomedical companies, totalling $3,150, including $1,750 from GW Research LimitedSubjects: Diet, Ketogenic; Intensive Care Units; Sleep Wake DisordersCategories: Diet Therapy; Methods
These expert listings are
for individual use without a fee. Biotechs,
Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and
other organizations may use this only for quick evaluations (no downloads, screen scraping or using the data) to identify the top medical experts for recruiting, advisory panels, boards,
and consulting. Please contact
us for licensing, customized queries, feedback and questions.
Note:
- Only the top 20 experts are shown. You may filter your results or use the geolocation tabs. Contact us to purchase the entire list.